
SHINE moving from R&D into the commercial stage for cancer therapy product, exec says
The head of SHINE Technologies’ therapeutics division says the company is moving from research and development into the commercial stage for a precision cancer treatment product. The Janesville company recently submitted its “drug master file” to the FDA, which includes


















